drugset / Trial / NCT05575999

Effectiveness of Bupivacaine, Ketorolac, Ketamine, vs Bupivacaine Alone in Reducing Postoperative Pocket Pain

NCT05575999

RandomizedParallel-groupOpen-labelTreatment

Summary

Bupivacaine is the most widely used local anesthetic agent across majority of the Cardiac Implantable Electronic device (CIED) implant procedures in the United States. It is hypothesized that the combination of Bupivacaine-Ketorolac-Ketamine (BKK) is more effective in alleviating perioperative and postoperative pain as compared to the use of bupivacaine alone. A few studies have been done to look for the effectiveness of BKK in abdominal surgical procedures. However, no study has been done to evaluate its efficacy and effectiveness in patients undergoing CIED insertion.

Timeline

Start
2026-01
Primary completion
2026-10
Completion
2026-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 60 mg Other
Subject Bupivacaine Other / unclassified 100 mg Other
Subject Ketamine Small molecule 24 mg Other
Subject Ketorolac Other / unclassified 24 mg Other

Indications

No indication recorded.